ARS Pharmaceuticals, Inc.
SPRY· Nasdaq· Pharmaceutical Preparations
- Market cap
- –
- P/FCF
- –
- EV/Sales
- –
- FCF margin
- -203.1%
- ROIC, 5 yr avg
- –
- Revenue, 5 yr CAGR
- –
We record prices for the companies we cover; SPRY is not one of them yet.
Company statistics
Profile · FY2025
- Market cap
- –
- Enterprise value
- –
- Diluted shares
- 98.6M
- Revenue
- $84.3M
- Free cash flow
- -$171.2M
- Owner earnings
- -$193.3M
Valuation · FY2025
- P/E
- –
- P/FCF
- –
- P/Owner earnings
- –
- EV/Sales
- –
- EV/FCF
- –
- P/B
- –
Margins · FY2025
- Gross
- –
- Operating
- -212.9%
- Net
- -203.3%
- Free cash flow
- -203.1%
- Owner earnings
- -229.4%
- Stock pay
- 26.2%
Returns
- ROIC, FY2025
- –
- ROIC, 5 yr avg
- –
- ROE, FY2025
- -149.9%
- ROE, 5 yr avg
- –
Growth (CAGR)
- Revenue, 3 yr
- 300.1%
- Revenue, 5 yr
- –
- Diluted EPS, 3 yr
- –
- Diluted EPS, 5 yr
- –
- Free cash flow, 3 yr
- –
- Free cash flow, 5 yr
- –
Financial health · FY2025
- Cash and investments
- $245.0M
- Total debt
- $96.4M
- Net cash
- $148.6M
- Debt/Equity
- 0.8x
- Debt/FCF
- –
Shareholder returns · FY2025
- Dividend yield
- –
- Payout ratio
- –
- Buyback yield
- –
- Shareholder yield
- –
- Share count, 5 yr
- –
Financials: ten years from the 10-Ks
Revenue
$84.3M
+97.8% a year over 5 years
FY2020FY2025
Margins
Operating-212.9%Net-203.3%
FY2025
FY2020FY2025
Free cash flow and owner earnings
Free cash flow-$171.2MOwner earnings-$193.3M
FY2025
FY2020FY2025
Diluted shares
98.6M
+241.4% over 5 years, net dilution
FY2020FY2025
Net cash
$148.6M
$148.6M more cash than debt
FY2020FY2025
Every figure, year by year
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| The business | ||||||
| Revenue | – | $5.5M | $1.3M | $30.0K | $89.1M | $84.3M |
| Revenue growth | – | – | -76.1% | -97.7% | 297063.3% | -5.5% |
| Gross margin | – | – | – | – | – | – |
| Operating margin | – | -353.3% | -2698.8% | -225066.7% | -3.5% | -212.9% |
| Net income | -$32.9M | -$20.2M | -$34.7M | -$54.4M | $8.0M | -$171.3M |
| Net margin | – | -367.7% | -2635.4% | -181216.7% | 9.0% | -203.3% |
| Diluted EPS | – | $-0.70 | $-0.87 | $-0.57 | $0.08 | $-1.74 |
| Return on invested capital? | – | – | – | – | – | – |
| Cash | ||||||
| Operating cash flow | -$31.2M | -$17.6M | -$40.1M | -$59.3M | $13.5M | -$170.9M |
| Capital expenditure | $917.0K | $55.0K | $199.0K | $175.0K | $563.0K | $339.0K |
| Free cash flow | -$32.1M | -$17.6M | -$40.3M | -$59.4M | $13.0M | -$171.2M |
| Stock-based compensation | $2.6M | $2.8M | $5.8M | $9.2M | $14.5M | $22.1M |
| Owner earnings? | -$34.8M | -$20.4M | -$46.1M | -$68.7M | -$1.5M | -$193.3M |
| Free cash flow per share | – | $-0.61 | $-1.01 | $-0.62 | $0.13 | $-1.74 |
| Capital allocation | ||||||
| Dividends paid | – | – | – | – | – | – |
| Share repurchases | – | – | – | – | – | – |
| Diluted shares | – | 28.9M | 40.0M | 95.2M | 102.4M | 98.6M |
| Share count change? | – | – | 38.4% | 138.3% | 7.5% | -3.7% |
| Balance sheet | ||||||
| Cash and equivalents | $386.6M | $60.1M | $210.5M | $71.0M | $50.8M | $41.3M |
| Short-term investments | – | $0 | $63.9M | $157.4M | $263.2M | $203.7M |
| Total debt | – | – | – | – | $0 | $96.4M |
| Net debt | – | – | – | – | -$314.0M | -$148.6M |
| Shareholders' equity | -$14.1M | -$31.3M | $272.9M | $230.8M | $256.8M | $114.3M |
Latest filings
| 2026-08-13 | 10-Q | Quarterly report |
| 2026-08-13 | 8-K | Earnings release |
| 2026-05-15 | 10-Q | Quarterly report |
| 2026-05-15 | 8-K | Earnings release |
| 2026-04-29 | DEF 14A | Proxy statement |
| 2026-03-09 | 10-K | Annual report |
| 2026-03-09 | 8-K | Earnings release |
| 2025-11-10 | 10-Q | Quarterly report |
| 2025-11-10 | 8-K | Earnings release |
| 2025-08-13 | 10-Q | Quarterly report |
More from our coverage
- MSFTPlatforms8.4MicrosoftThe most entrenched software franchise in the enterprise, now spending its cash flow on AI capacity; a great business we would own with a margin of safety, not at any price.Base value $410.29
- NVDAAI infrastructure8.4NVIDIAThe best business in technology at the top of its cycle: the moat is CUDA as much as silicon, but today's margins are a peak, not a floor.Base value $104.32
- AAPLHardware7.6AppleOne of the highest-quality businesses in the world growing in the low single digits; the price usually assumes more growth than the numbers show.Base value $134.27
- GOOGLPlatforms7.4AlphabetSearch pays for everything, and AI is both its biggest threat and its biggest opportunity; the price has to allow for search being worth less than it was.Base value $209.60
- NOWSoftware7.4ServiceNowA rare enterprise platform still growing above 20% with high retention; the free cash flow is real but stock pay takes a large share of it.Base value $189.13
- ADBESoftware7.4AdobeSuperb margins and a shrinking share count, priced for decline; the question is whether AI makes Adobe's tools more valuable or makes them unnecessary.Base value $449.35
